| Bioactivity | PF-00956980 is a reversible pan-JAK inhibitor with IC50 values of 2.2, 23.1 and 59.9 μM for JAK1, JAK2 and JAK3, respectively. PF-00956980 can be used in the research of lung and skin inflammatory diseases[1]. |
| In Vivo | The pharmacokinetic parameters of PF-00956980(compound 2) in rat or dog Spesies |
| Name | PF-00956980 |
| CAS | 1262832-74-5 |
| Formula | C18H26N6O |
| Molar Mass | 342.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Peter Jones, et al. Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. J Med Chem. 2017 Jan 26;60(2):767-786. |
PF-00956980
CAS: 1262832-74-5 F: C18H26N6O W: 342.44
PF-00956980 is a reversible pan-JAK inhibitor with IC50 values of 2.2, 23.1 and 59.9 μM for JAK1, JAK2 and JAK3, respec
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.